The 7^th Symposium on Primary Breast Cancer in Older Women

Figures & data

Table

Information to delegates:
Wifi:	Is available free of charge in the Jubilee Hotel & Conferences
Programme, speakers’ profiles and abstracts	www.futuremedicine.com/doi/epdf/10.2217/fon-2024-0144
Slides:	Copies of the slides presented at the Symposium will be available on the Symposia webpage below following the event
Useful links:	Symposia webpage	www.nottingham.ac.uk/medicine/breastmeetings
	University of Nottingham	www.nottingham.ac.uk
	International Society of Geriatric Oncology (SIOG)	www.siog.org

Evaluation forms: You will be provided with a QR code to a feedback form on the day, after you have registered your attendance, you will be sent your certificate of attendance upon completion of the feedback form.

Table

	Presentation	Speaker	Affiliations
09:45–10:00	Welcome and introduction	Kwok-Leung Cheung	Professor of Breast Surgery and Medical Education, University of Nottingham; Consultant Breast Surgeon, University Hospitals of Royal Derby and Burton Hospital; UK National Representative, SIOG; Symposium Chair

Table

	Presentation	Speaker	Affiliations
10:00–10:30	Updates	Etienne Brain	Medical Oncologist, Institute Curie, Paris, France; Past President, SIOG
10:30–11:00	Challenges in clinical trials participation	Ruth Parks
11:00–11:15	Discussion	Panel

Table

	Presentation	Speaker	Affiliations
11:35–12:20	Oral Abstracts
12:20–12:40	MDT case discussion	Panel

Table

	Presentation	Speaker	Affiliations
13:40–14:10	Neoadjuvant endocrine therapy – the Edinburgh experience	J Michael Dixon	Professor of Surgery and Consultant, Edinburgh Breast Unit, Western General Hospital, Edinburgh
14:10–14:40	Polypharmacy – is it relevant?	Holly Holmes	Vice President and Joan and Stanford Alexander Chair in Gerontology; Professor, UTHealth Houston, McGovern Medical School, USA
14:40–14:55	Discussion	All faculty

Table

	Presentation	Speaker	Affiliations
15:15–16:05	Interviewing patients and caregivers	Facilitated by Joanne York	Consultant Radiographer, Royal Derby Hospital
16:05–16:35	Involving patients and caregivers	Holly Holmes	Vice President and Joan and Stanford Alexander Chair in Gerontology; Professor, UTHealth Houston, McGovern Medical School, USA
16:35–16:45	Conclusion – summary and ways forward	Etienne Brain	Medical Oncologist, Institute Curie, Paris, France; Past President, SIOG

Table

	Kwok-Leung Cheung Kwok-Leung Cheung is Professor of Breast Surgery and Medical Education at the University of Nottingham. He qualified and trained in Hong Kong, was appointed as Consultant Breast Surgeon, Nottingham University Hospitals in 2001, and is now an Honorary Consultant Breast Surgeon at the University Hospitals of Derby and Burton. Professor Cheung has clinical and research interests in breast cancer and geriatric oncology. He has served many roles in the International Society of Geriatric Oncology (SIOG) where he is currently the Treasurer and Member of the Board and Executive Committee, and its UK National Representative. He is also a member of the Executive Committee of the European Society of Breast Cancer Specialists (EUSOMA), and of the Breast Cancer Clinical Guidelines Committee of the National Institute for Health and Care Excellence (NICE).
	J Michael Dixon I am the senior consultant breast surgeon in the Edinburgh Breast Unit at the Edinburgh Cancer Centre. I have a Personal Chair in Breast Surgical Oncology from the University of Edinburgh and I am Clinical Director of the Edinburgh Breast Cancer Now Research Group within the University’s Institute of Genetics and Cancer. I was awarded the Order of the British Empire (OBE) Medal from HRH Queen Elizabeth II in 2013 for my work on improving understanding of breast diseases as well as the optimal management of benign and malignant breast conditions. I pride myself on the patient centred care I provide and offer the full range of surgical options for the management of all breast disease including specialist surgical oncology procedures for immediate and delayed breast reconstruction, and I work closely with my Plastic Surgery colleagues to deliver these. My research focuses on the use of endocrine agents in the management of breast cancer and endocrine drug resistance. I have pioneered the development and use of aromatase inhibitors worldwide given in the neoadjuvant setting in large operable and locally advanced breast cancers. I have developed new operative procedures to improve cosmetic outcomes including immediate lipofilling at the same time as cancer excision, and the use of lipofilling LD flaps in breast reconstruction. My work has advanced understanding and management of common benign breast conditions that have improved outcomes for patients internationally.
	Ruth Parks Ruth Parks is a breast surgery trainee in the East Midlands, UK and Honorary Assistant Professor at the University of Nottingham. She completed her PhD at the University of Nottingham in 2023 investigating the detailed biology of breast cancer in older women. Ruth was awarded a competitive fellowship from Nottingham Hospitals charity in order to complete this work and also an honorary fellowship from the Royal College of Surgeons of England. Ruth is a member of the International Society of Geriatric Oncology (SIOG) and is the Midlands representative for the Mammary Fold.
	Joanne York Joanne York has worked in breast care for many years. In 1991 she worked at the Nottingham breast unit as a mammographer, later working also as a mammography trainer. In 2003 she joined the Derby breast unit as an advanced practitioner. This role was influential to Joanne, encouraging her to extend her role. In 2013 she gained a Master’s qualification in advanced practice and became a consultant radiographer. Joanne is now an integral part of the Radiology team within the Derby and Burton breast unit. Leading the radiology for the patients on primary endocrine therapy, she has an interest in improving the patient experience for older patients and patients with learning disabilities.
	Etienne Brain Etienne Brain, MD with a board certification in medical oncology (1993), works at Institut Curie since 1998. After a fellowship in Boston in 1996 (Dana Farber Cance Institute and Boston University), he obtained a PhD in 2005 from Université Paris V and a research supervision accreditation from Université Versailles/Saint-Quentin in 2010. He got a diploma in management and health economics from Bocconi University (Milan, IT, 2015). For more than 20 years, he has been very involved in clinical research for breast cancer and for cancer in older patients. He chaired the group GERICO (Unicancer) and the intergroup DIALOG labeled by INCa, both dedicated to clinical research for cancer in older persons. He chaired the breast cancer group of the European Organisation for Research and Treatment of Cancer (EORTC), and he is the EORTC Secretary General since 2021. He is an executive board member of the Breast International Group and past-president of the International Society of Geriatric Oncology. His works address the management of breast cancer, especially in older patients. He received the B.J. Kennedy Award for Scientific Excellence in Geriatric Oncology (ASCO 2022), the Michel Hery geriatric oncology Award (Monaco Age Oncology conference 2023) and the Prix Albert 1er of the Académie Nationale de Médecine (Biennale Monégasque de Cancérologie 2024).
	Holly Holmes Dr Holly Holmes is a professor and Joan and Stanford Alexander Chair in Gerontology. She is the Director of the Alexander Division of Geriatric and Palliative Medicine at McGovern Medical School at UTHealth in Houston, Texas. She is a geriatrician and epidemiologist, and a former pharmacist. Her clinical care is focused on comprehensive geriatric assessment, particularly in older adults with cancer. Her clinical and research interests are centered on optimizing medication use care for vulnerable older adults.

Table

			Surgery	Treatment Primary Systemic Therapy	No Treatment	Total
Age	<70	Count	201	4	1	206
		% within Age	97.6	1.9	0.5	100.0
	≥70	Count	83	34	4	121
		% within Age	68.6	28.1	3.3	100.0
Total		Count	284	38	5	327
		% within Age	86.9	11.6	1.5	100.0